Nathalie Broutet

ORCID: 0000-0002-3665-4861
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cervical Cancer and HPV Research
  • Syphilis Diagnosis and Treatment
  • Reproductive tract infections research
  • Helicobacter pylori-related gastroenterology studies
  • Global Cancer Incidence and Screening
  • Mosquito-borne diseases and control
  • Eosinophilic Esophagitis
  • Viral Infections and Vectors
  • Adolescent Sexual and Reproductive Health
  • Genital Health and Disease
  • COVID-19 Impact on Reproduction
  • Viral Infections and Outbreaks Research
  • Gastroesophageal reflux and treatments
  • Global Maternal and Child Health
  • COVID-19 epidemiological studies
  • Gastric Cancer Management and Outcomes
  • Vaccine Coverage and Hesitancy
  • HIV/AIDS Research and Interventions
  • Female Genital Mutilation/Cutting Issues
  • Hepatitis B Virus Studies
  • Virology and Viral Diseases
  • Reproductive Health and Contraception
  • Galectins and Cancer Biology
  • Maternal Mental Health During Pregnancy and Postpartum
  • Prenatal Screening and Diagnostics

World Health Organization
2015-2024

John Wiley & Sons (United States)
2023

Hudson Institute
2023

World Health Organization - Pakistan
2007-2022

University of Birmingham
2021

Centers for Disease Control and Prevention
2019

Université de Bordeaux
1996-2005

Hôpital Pellegrin
2000-2002

Kagoshima University
2001

Jorvi Hospital
2001

To generate estimates of the global prevalence and incidence urogenital infection with chlamydia, gonorrhoea, trichomoniasis syphilis in women men, aged 15-49 years, 2016.For gonorrhoea trichomoniasis, we systematically searched for studies conducted between 2009 2016 reporting prevalence. We also consulted regional experts. estimates, used Bayesian meta-analysis. For syphilis, aggregated national generated by using Spectrum-STI.For and/or 130 were eligible. Spectrum-STI database contained...

10.2471/blt.18.228486 article CA cc-by Bulletin of the World Health Organization 2019-06-06

The WHO Director-General has issued a call for action to eliminate cervical cancer as public health problem. To help inform global efforts, we modelled potential human papillomavirus (HPV) vaccination and screening scenarios in low-income lower-middle-income countries (LMICs) examine the feasibility timing of elimination at different thresholds, estimate number cases averted on path elimination.The Cervical Cancer Elimination Modelling Consortium (CCEMC), which consists three independent...

10.1016/s0140-6736(20)30068-4 article EN cc-by-nc-nd The Lancet 2020-01-30

WHO is developing a global strategy towards eliminating cervical cancer as public health problem, which proposes an elimination threshold of four cases per 100 000 women and includes 2030 triple-intervention coverage targets for scale-up human papillomavirus (HPV) vaccination to 90%, twice-lifetime screening 70%, treatment pre-invasive lesions invasive 90%. We assessed the impact achieving 90-70-90 on mortality deaths averted over next century. also potential initiative support target 3.4 UN...

10.1016/s0140-6736(20)30157-4 article EN cc-by-nc-nd The Lancet 2020-01-30

The World Health Organization initiative to eliminate mother-to-child transmission of syphilis aims for ≥ 90% pregnant women be tested and receive treatment by 2015. We calculated global regional estimates in pregnancy associated adverse outcomes 2008, as well antenatal care (ANC) coverage with syphilis.Estimates were based upon a health service delivery model. National seropositivity data from 97 193 countries ANC 147 obtained databases. Proportions effectiveness screening published...

10.1371/journal.pmed.1001396 article EN cc-by PLoS Medicine 2013-02-26

Background In 2007 the World Health Organization (WHO) launched global initiative to eliminate mother-to-child transmission of syphilis (congenital syphilis, or CS). To assess progress towards goal <50 CS cases per 100,000 live births, we generated regional and estimates maternal congenital for 2016 updated 2012 estimates. Methods Maternal were using Spectrum-STI model, fitted sentinel surveys routine testing pregnant women during antenatal care (ANC) other representative population data....

10.1371/journal.pone.0211720 article EN public-domain PLoS ONE 2019-02-27

Ebola virus has been detected in the semen of men after their recovery from disease (EVD). We report presence RNA a cohort survivors EVD Sierra Leone.We enrolled convenience sample 220 adult male Leone, at various times discharge an treatment unit (ETU), two phases (100 participants were phase 1, and 120 2). Semen specimens obtained baseline tested by means quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay with use target sequences NP VP40 (in 1) or GP This study...

10.1056/nejmoa1511410 article EN New England Journal of Medicine 2015-10-14

In 2007, WHO launched a global initiative for the elimination of mother-to-child transmission syphilis (congenital syphilis). An important aspect is strengthening surveillance to monitor progress towards elimination. 2008, using health systems model with country data inputs, estimated that 1·4 million maternal infections caused 520 000 adverse pregnancy outcomes. To assess progress, we updated 2008 estimates and 2012 prevalence cases congenital syphilis.We used approved by Child Health...

10.1016/s2214-109x(16)30135-8 article EN cc-by-nc-nd The Lancet Global Health 2016-07-18

Cervical cancer is the fourth most common among women globally, with an estimated 570 000 new cases and 311 deaths worldwide in 2018.[1–3][1] The highest regional incidence mortality rates are seen Africa, where 7–10 times higher than western world.[1 2

10.1136/ijgc-2020-001285 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2020-03-02
Coming Soon ...